Platelet-activating factor acetylhydrolase (PAF-AH) therapeutic uses
US6099836A · kind A · utility
7Cited by
5References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 19, 1998 |
| Grant date | Aug 8, 2000 |
| Priority date | — |
| Expiry date | Jun 19, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Also provided are materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products which are expected to be useful in regulating pathological inflammatory events. Specifically disclosed are methods for the treatment of reperfusion injury using platelet-activating factor acetylhydrolase products.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.